Frequently Asked Questions

Two stacked light blue Kleenex tissue boxes with tissues protruding from the top box, against a soft blue background with sheer curtains.
Red package of Huggies Little Snugglers diapers featuring a sleeping baby, leak protection info, and 31 diapers count.
Bottle of Listerine Cool Mint mouthwash labeled zero alcohol, killing 99.9% of bad breath germs with less intense taste.
Close-up of a Johnson's baby shampoo bottle with foam bubbles and ‘no more tears’ label on yellow background.
Package of U by Kotex Clean & Secure Ultra Thin Ultraminces pads with a blue and white pad image and text highlighting cushion core absorption and no harsh ingredients.
Smiling man wearing a black shirt and Depend protective underwear standing inside a large Depend Fresh Protection Maximum package.
Bottle of Aveeno Eczema Therapy Daily Moisturizing Cream with colloidal oatmeal on a pink background.
Jar of Neutrogena Hydro Boost Water Cream with a white lid on a green surface against a light blue background.
Cottonelle Ultra Clean toilet paper roll and a pack of Cottonelle Flushable Wipes Fresh Care on a blue surface with a wavy blue background.
Bottle of Tylenol Extra Strength pain reliever and fever reducer with red cap on pink background.
Smiling man wearing a black shirt and Depend protective underwear standing inside a large Depend Fresh Protection Maximum package.
Bottle of Aveeno Eczema Therapy Daily Moisturizing Cream with colloidal oatmeal on a pink background.
Jar of Neutrogena Hydro Boost Water Cream with a white lid on a green surface against a light blue background.
Cottonelle Ultra Clean toilet paper roll and a pack of Cottonelle Flushable Wipes Fresh Care on a blue surface with a wavy blue background.
Bottle of Tylenol Extra Strength pain reliever and fever reducer with red cap on pink background.
Two stacked light blue Kleenex tissue boxes with tissues protruding from the top box, against a soft blue background with sheer curtains.
Red package of Huggies Little Snugglers diapers featuring a sleeping baby, leak protection info, and 31 diapers count.
Bottle of Listerine Cool Mint mouthwash labeled zero alcohol, killing 99.9% of bad breath germs with less intense taste.
Close-up of a Johnson's baby shampoo bottle with foam bubbles and ‘no more tears’ label on yellow background.
Package of U by Kotex Clean & Secure Ultra Thin Ultraminces pads with a blue and white pad image and text highlighting cushion core absorption and no harsh ingredients.
Why is Kimberly-Clark acquiring Kenvue?
  • Kimberly-Clark is acquiring Kenvue to create a global leader in health and wellness.
  • Kimberly-Clark’s acquisition of Kenvue:
    • Combines Kimberly-Clark’s and Kenvue’s highly complementary and strategically aligned consumer offerings and shared commitment to developing science and technology to provide extraordinary care for billions of consumers across every stage of life;
    • Applies Kimberly-Clark’s proven commercial execution playbook to create a best-in-class consumer-driven company;
    • Accelerates Kenvue’s premier consumer health portfolio and unlocks new opportunities for science-backed innovation supported by Kenvue’s talented team to deliver higher-quality products at a greater value for consumers;
    • Enhances investment in marketing, innovation and R&D capabilities to strengthen the combined company’s unique advantages; and
    • Delivers immediate upfront value to Kenvue shareholders with the opportunity to participate in significant future upside from combined value creation.
Who is Kenvue? What brands does Kenvue own?
  • Kenvue is one of the world’s largest pure-play consumer health companies, uniquely positioned at the intersection of consumer packaged goods (CPG) and healthcare, with exceptional talent and a differentiated brand offering serving attractive consumer health categories.
  • Kenvue’s brands include, among others, Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, which have helped generations take care of themselves and their loved ones for more than 135 years.
How will the Kimberly-Clark and Kenvue transaction benefit consumers?
  • Together, Kimberly-Clark and Kenvue will benefit from a highly complementary and strategically aligned consumer offering. Touching nearly half of the global population across every stage of life, the combined company will be well positioned to advance innovation in consumer care around the world by leveraging shared expertise in science and technology, as well as a deep commitment to caring.
  • By combining Kimberly-Clark’s personal care solutions across adult care, baby care, family care and feminine care with Kenvue’s premier consumer health portfolio, we will be even better positioned to meet consumers’ unmet and evolving needs.
What brands are included in the Kimberly-Clark and Kenvue transaction?
  • Kimberly-Clark’s acquisition of Kenvue creates a combined portfolio of complementary products, including 10 iconic billion-dollar brands, that touch nearly half the global population through every stage of life.
  • These brands include, among others, Cottonelle®, Depend®, Huggies®, Johnson’s®, Kleenex®, Kotex®, Listerine®, Neutrogena®, Scott® and Tylenol®.
When will the Kimberly-Clark and Kenvue transaction close?
  • The Kimberly-Clark and Kenvue transaction is expected to close in the second half of 2026, subject to regulatory approvals and satisfaction of other customary closing conditions.
How will the Kimberly-Clark and Kenvue transaction create value for combined shareholders?
  • The Kimberly-Clark and Kenvue transaction offers a compelling opportunity for significant value creation, supported by a strong balance sheet and financial flexibility.
  • Key highlights include:
    • Attractive Financial Profile: Based on current projections, the transaction significantly enhances cash flow generation, enabling rapid deleveraging and providing flexibility for significant reinvestment, management of upcoming debt maturities and long-term financial health.
    • Clear Path to Strong Cost and Revenue Synergies: Kimberly-Clark and Kenvue have identified approximately $1.9 billion in cost synergies and approximately $500 million in incremental profit from revenue synergies, partially offset by reinvestment of approximately $300 million. Kimberly-Clark expects $2.5 billion of cash costs to achieve these synergies, invested within the first two years post close.
    • Powerful Financial Algorithm Positioned to Drive Shareholder Value:
      • Organic growth ahead of weighted average category growth;
      • Top-tier adjusted operating profit and adjusted constant currency EPS growth; and
      • Double-digit total shareholder return over time.
When is Kimberly-Clark’s shareholder vote?
  • Kimberly-Clark is hosting its special meeting of stockholders on January 29, 2026 at 8:00 a.m., Central Time.
When is Kenvue’s shareholder vote?
  • Kenvue is hosting its special meeting of stockholders on January 29, 2026 at 9:00 a.m., Eastern Time.
I’m a Kimberly-Clark shareholder. How do I vote?
  • You can vote:
    • Online - Visit the website or scan the QR code found on your proxy card or voting instruction form;
    • By phone - Call the toll-free number found on your proxy card or voting instruction form;
    • By mail - Complete, sign and return your proxy card or voting instruction form in the provided postage-paid envelope in accordance with the instructions set forth within the proxy card or voting instruction form; or
    • During the Kimberly-Clark special meeting (up until the closing of the polls) – Visit https://meetnow.global/MZG69WX and use the control number found on your proxy card or voting instruction form and follow the instructions available on the website.
I’m a Kenvue shareholder. How do I vote?
  • You can vote:
    • Online - Visit www.proxyvote.com and enter the 16-digit control number found on your proxy card or voting instruction form;
    • By phone - Call 1-800-690-6903, the toll-free number found on your proxy card or voting instruction form;
    • By mail - Complete, sign and return your proxy or voting instruction card in the envelope provided; or
    • During the Kenvue special meeting (up until the closing of the polls) – Visit www.virtualshareholdermeeting.com/KVUE2026SM and enter the 16-digit control number found on your proxy card or voting instruction form and follow the instructions available on the website.
Who can I contact if I have questions regarding Kimberly-Clark’s special meeting?
  • If you need assistance in completing your proxy card or have questions regarding the Kimberly-Clark special meeting, contact Innisfree M&A Incorporated:
    • 501 Madison Avenue, 20th Floor, New York, New York 10022
      Banks and Brokers Call Collect: (212) 750-5833
      All Others Call Toll-Free: (877) 800-5187
Who can I contact if I have questions regarding Kenvue’s special meeting?
  • If you need assistance in completing your proxy card or have questions regarding the Kenvue special meeting, contact D.F. King & Co., Inc.:
    • 28 Liberty Street, 53rd Floor, New York, New York 10005
      Banks and brokers, please call: (646) 845-0148
      All others, please call toll-free: (800) 848-3405
      Email: kenvue@dfking.com